Samsung Biologics and LegoChem enter ADC development deal
Samsung Biologics has entered into a strategic partnership with LegoChem Biosciences to advance ADC programmes aimed at treating solid tumours.
📰 Legochem Bioscience News
Legochem Bioscience News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Legochem Bioscience. Real-time updates on events, politics, business and more.
Samsung Biologics partners with LegoChem Biosciences for ADC development and manufacturing
- Samsung Biologics to develop and manufacture antibody for ADC candidate - Latest deal comes as Samsung Biologics is on track to complete construction of an ADC facility this year INCHEON, South Korea, Feb. 7, 2024
South Korea Inch On Gwangyoksi Samsung Biologics Claire Kim Prnewswire Samsung Biologics Daeyoung Jeong
Source: benzinga.com
Orion seeks new growth engine via majority stake in LegoChem Biosciences
On Monday, the confectionery and beverage company announced that it would invest 550 billion won ($414 million) to acquire a 25 percent stake in LegoChem. It will secure the stake by participating in LegoChem’s paid-in capital increase and acquiring shares from major shareholders. The payment is due on March 29.
Taejon Gwangyoksi South Korea Baek Byung Yeul Legochem Biosciences Bioscience Orion Biologics Legochem Biosciences
Source: koreatimes.co.kr